A Study to Evaluate Long-Term Outcomes of Gastroesophageal Reflux Disease (GERD)


About this study

The purpose of this study is to collect data related to patients undergoing diagnostic evaluation and treatment of Gastroesophageal Reflux Disease (GERD) and its associated diseases in multiple academic and community settings.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Potential participants must be age 18 years old or older.
  • Able to read, comprehend, and complete the informed consent form (provide informed consent).
  • Willing to participate in a long-term follow-up at least 5 years.
  • Has symptoms or signs of chronic GERD (including heartburn, regurgitation, atypical chest pain, dysphagia or trouble swallowing, sore throat, voice hoarseness, cough, asthma), or a confirmed diagnosis of GERD, laryngopharyngeal reflux, Barrett’s esophagus, eosinophilic esophagitis, reflux esophagitis, reflux-related esophageal stricture).

Exclusion Criteria:  

  • None.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Barham Abu Dayyeh, M.D., M.P.H.

Open for enrollment

Contact information:

Erik Hyland B.S.



More information


Publications are currently not available

Mayo Clinic Footer